ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 59 filers reported holding ADICET BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,182,880 | -44.9% | 4,283,372 | +6.9% | 0.00% | -50.0% |
| Q1 2024 | $9,413,130 | +17306.6% | 4,005,587 | +13899.2% | 0.00% | – |
| Q4 2023 | $54,078 | -33.7% | 28,613 | -51.9% | 0.00% | – |
| Q3 2023 | $81,530 | -52.1% | 59,511 | -15.0% | 0.00% | – |
| Q2 2023 | $170,073 | -70.3% | 69,989 | -29.5% | 0.00% | – |
| Q1 2023 | $572,002 | -77.8% | 99,306 | -65.5% | 0.00% | -100.0% |
| Q4 2022 | $2,576,749 | +45765.9% | 288,227 | -27.0% | 0.00% | 0.0% |
| Q3 2022 | $5,618 | +11.4% | 395,081 | +14.3% | 0.00% | 0.0% |
| Q2 2022 | $5,045 | -99.9% | 345,547 | +51.5% | 0.00% | 0.0% |
| Q1 2022 | $4,554,000 | +59.2% | 228,031 | +39.4% | 0.00% | 0.0% |
| Q4 2021 | $2,861,000 | +860.1% | 163,625 | +330.4% | 0.00% | – |
| Q3 2021 | $298,000 | +86.2% | 38,016 | +144.2% | 0.00% | – |
| Q2 2021 | $160,000 | -73.2% | 15,565 | -66.0% | 0.00% | – |
| Q1 2021 | $598,000 | +315.3% | 45,755 | +346.8% | 0.00% | – |
| Q4 2020 | $144,000 | – | 10,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $42,160,000 | 11.96% |
| Foresite Capital Management V, LLC | 680,000 | $13,580,000 | 5.55% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $3,395,000 | 4.75% |
| Tri Locum Partners LP | 523,256 | $10,449,000 | 4.08% |
| DAFNA Capital Management LLC | 715,872 | $14,296,000 | 3.72% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $11,583,000 | 3.55% |
| COWEN AND COMPANY, LLC | 1,500,055 | $29,956,000 | 2.88% |
| JOHNSON & JOHNSON | 728,944 | $14,557,000 | 2.75% |
| Orbimed Advisors | 7,447,141 | $148,719,000 | 2.41% |
| Ikarian Capital, LLC | 507,348 | $10,132,000 | 1.33% |